E-LIB Suche - Ergebnisse für: Roblin, X

1

P602 Risankizumab levels but not IL22 are significantly cor..:

Roblin, X ; barrau, M ; Duru, G..
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1169-i1169 , 2024

Link: https://doi.org/10.1093/..

2

P437 Feasibility study of a Point-of-Care assay for rapid d..:

Ricken, B ; Brosi, L ; Reinhard, C...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i895-i895 , 2024

Link: https://doi.org/10.1093/..

3

P322 Compared Efficacy of Second-Line Treatments for Ulcera..:

Calmejane, L ; Reenaers, C ; Amiot, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i707-i707 , 2024

Link: https://doi.org/10.1093/..

4

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1686-i1686 , 2024

Link: https://doi.org/10.1093/..

5

P807 HLA type impact on immunization and efficacy of usteki..:

Delmeule, A ; Dubois, V ; gay, C...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1503-i1503 , 2024

Link: https://doi.org/10.1093/..

6

P884 Patient satisfaction and experience after a switch to ..:

Bouguen, G ; Gossec, L ; Abitbol, V...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1627-i1627 , 2024

Link: https://doi.org/10.1093/..

7

P144 Impact of major medication discontinuation during the ..:

Meunier, C ; Monte, C ; Hadjisavvas, H...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i306-i306 , 2023

Link: https://doi.org/10.1093/..

8

P494 Impact of early optimization of ustekinumab on mid-ter..:

Abdelmoula, A ; Chateau, T ; Hupe, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i625-i625 , 2023

Link: https://doi.org/10.1093/..

9

P682 Development of anti-ustekinumab antibodies is an indep..:

Roblin, X ; Nancey, S ; Bastide, L...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i814-i814 , 2023

Link: https://doi.org/10.1093/..

10

P537 Prevalence of post-COVID-19 vaccination IBD flare-ups:..:

Roblin, X ; Williet, N ; Faure, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i665-i666 , 2023

Link: https://doi.org/10.1093/..

11

P638 Effectiveness and safety of risankizumab induction the..:

Fumery, M ; Defrance, A ; Roblin, X...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i770-i770 , 2023

Link: https://doi.org/10.1093/..

12

P793 Infliximab and prevention of colectomy in acute severe..:

Wang, Z ; Afif, W ; Hanžel, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i925-i926 , 2023

Link: https://doi.org/10.1093/..

13

P319 Characteristics of filgotinib-treated patients with Ul..:

Kobayashi, T ; Dignass, A ; Roblin, X...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i459-i460 , 2023

Link: https://doi.org/10.1093/..

14

OP14 Prevention of postoperative recurrence of Crohn's dise..:

D'Haens, G ; Taxonera, C ; Lopez-Sanroman, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i19-i19 , 2023

Link: https://doi.org/10.1093/..

15

How to Manage Inflammatory Bowel Disease Patients When They..:

Cottron, C ; Treton, X ; Altwegg, R...
Journal of Crohn's and Colitis. 16 (2022) 8 - p. 1202-1210 , 2022

Link: https://doi.org/10.1093/..